Nicox S.A.
Records under this name other than the patents Nicox S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,058,691 | Nitric Oxide Releasing Prostaglandin Derivatives for Treating Normal Tension Glaucoma Formerly held In force · High confidence | In force | High confidence | |
| US 11,660,282 | Method for treating vaso occlusive crises associated with sickle cell disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,674 | Nitric Oxide Enhancing Prostaglandin Compounds, Compositions and Methods of Use Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 10,047,047 | Nitric Oxide Donating Derivatives of Latanoprost Free Acid Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 9,895,335 | Ophthalmic compositions containing a nitric oxide donor Lapsed on the fee record Ended Feb 20, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2026 | From the USPTO record |
| US 7,273,946 | Prostaglandin Derivatives Term ended Term ended Oct 3, 2025 · High confidence | Term ended | Term ended Oct 3, 2025 | High confidence |
| US 9,598,349 | Quinone based nitric oxide donating compounds for ophthalmic use Lapsed on the fee record Ended Mar 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 21, 2025 | From the USPTO record |
| US 7,449,469 | Prostaglandin derivatives Term ended Ended no later than Jan 5, 2025 · From the USPTO record | Term ended | Ended no later than Jan 5, 2025 | From the USPTO record |
| US 7,629,345 | Prostaglandin derivatives Term ended Ended no later than Jan 5, 2025 · From the USPTO record | Term ended | Ended no later than Jan 5, 2025 | From the USPTO record |
| US 7,910,767 | Prostaglandin derivatives Term ended Ended no later than Jan 5, 2025 · From the USPTO record | Term ended | Ended no later than Jan 5, 2025 | From the USPTO record |